Broadfin Healthcare Master Fund Ltd - Net Worth and Insider Trading
Broadfin Healthcare Master Fund Ltd Net Worth
The estimated net worth of Broadfin Healthcare Master Fund Ltd is at least $358 Million dollars as of 2024-11-05. Broadfin Healthcare Master Fund Ltd is the 10% Owner of Mirati Therapeutics Inc and owns about 2,728,601 shares of Mirati Therapeutics Inc (MRTX) stock worth over $160 Million. Broadfin Healthcare Master Fund Ltd is the 10% Owner of Avadel Pharmaceuticals PLC and owns about 4,133,464 shares of Avadel Pharmaceuticals PLC (AVDL) stock worth over $62 Million. Broadfin Healthcare Master Fund Ltd is also the 10% Owner of Corium International Inc and owns about 3,568,626 shares of Corium International Inc (CORI) stock worth over $45 Million. Besides these, Broadfin Healthcare Master Fund Ltd also holds BioDelivery Sciences International Inc (BDSI) , Progenics Pharmaceuticals Inc (PGNX) , Aratana Therapeutics Inc (PETX) , Aegerion Pharmaceuticals Inc (AEGR) , Societal CDMO Inc (SCTL) , Novelion Therapeutics Inc (NVLNF) , Strata Skin Sciences Inc (SSKN) . Details can be seen in Broadfin Healthcare Master Fund Ltd's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Broadfin Healthcare Master Fund Ltd has not made any transactions after 2021-11-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Broadfin Healthcare Master Fund Ltd
Broadfin Healthcare Master Fund Ltd Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Broadfin Healthcare Master Fund Ltd owns 12 companies in total, including BioDelivery Sciences International Inc (BDSI) , Novelion Therapeutics Inc (NVLNF) , and Avadel Pharmaceuticals PLC (AVDL) among others .
Insider Ownership Summary of Broadfin Healthcare Master Fund Ltd
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
BDSI | BioDelivery Sciences International Inc | 2021-11-19 | director |
NVLNF | Novelion Therapeutics Inc | 2020-01-09 | 10 percent owner |
AVDL | Avadel Pharmaceuticals PLC | 2017-06-23 | 10 percent owner |
2019-07-18 | 10 percent owner | ||
2018-11-27 | 10 percent owner | ||
2018-05-24 | 10 percent owner | ||
2017-11-16 | 10 percent owner | ||
2017-02-15 | 10 percent owner | ||
2016-11-29 | 10 percent owner | ||
2016-03-11 | 10 percent owner | ||
2015-09-04 | 10 percent owner & other: See Explanation of Responses | ||
2015-01-13 | 10 percent owner |
Broadfin Healthcare Master Fund Ltd Latest Holdings Summary
Broadfin Healthcare Master Fund Ltd currently owns a total of 10 stocks. Among these stocks, Broadfin Healthcare Master Fund Ltd owns 2,728,601 shares of Mirati Therapeutics Inc (MRTX) as of November 16, 2017, with a value of $160 Million and a weighting of 44.73%. Broadfin Healthcare Master Fund Ltd owns 4,133,464 shares of Avadel Pharmaceuticals PLC (AVDL) as of June 23, 2017, with a value of $62 Million and a weighting of 17.33%. Broadfin Healthcare Master Fund Ltd also owns 3,568,626 shares of Corium International Inc (CORI) as of November 17, 2017, with a value of $45 Million and a weighting of 12.64%. The other 7 stocks BioDelivery Sciences International Inc (BDSI) , Progenics Pharmaceuticals Inc (PGNX) , Aratana Therapeutics Inc (PETX) , Aegerion Pharmaceuticals Inc (AEGR) , Societal CDMO Inc (SCTL) , Novelion Therapeutics Inc (NVLNF) , Strata Skin Sciences Inc (SSKN) have a combined weighting of 25.31% among all his current holdings.
Latest Holdings of Broadfin Healthcare Master Fund Ltd
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MRTX | Mirati Therapeutics Inc | 2017-11-16 | 2,728,601 | 58.70 | 160,168,879 |
AVDL | Avadel Pharmaceuticals PLC | 2017-06-23 | 4,133,464 | 15.01 | 62,043,295 |
CORI | Corium International Inc | 2017-11-17 | 3,568,626 | 12.68 | 45,250,178 |
BDSI | BioDelivery Sciences International Inc | 2021-11-19 | 5,158,489 | 5.59 | 28,835,954 |
PGNX | Progenics Pharmaceuticals Inc | 2017-02-15 | 6,997,269 | 4.10 | 28,688,803 |
PETX | Aratana Therapeutics Inc | 2017-12-01 | 4,294,426 | 4.92 | 21,128,576 |
AEGR | Aegerion Pharmaceuticals Inc | 2016-09-13 | 4,361,291 | 1.97 | 8,591,743 |
SCTL | Societal CDMO Inc | 2018-05-24 | 2,048,025 | 1.10 | 2,252,828 |
NVLNF | Novelion Therapeutics Inc | 2018-12-27 | 1,498,553 | 0.70 | 1,051,984 |
SSKN | Strata Skin Sciences Inc | 2016-03-11 | 20,166 | 3.10 | 62,515 |
Holding Weightings of Broadfin Healthcare Master Fund Ltd
Broadfin Healthcare Master Fund Ltd Form 4 Trading Tracker
According to the SEC Form 4 filings, Broadfin Healthcare Master Fund Ltd has made a total of 0 transactions in Mirati Therapeutics Inc (MRTX) over the past 5 years. The most-recent trade in Mirati Therapeutics Inc is the sale of 60,000 shares on November 16, 2017, which brought Broadfin Healthcare Master Fund Ltd around $1 Million.
According to the SEC Form 4 filings, Broadfin Healthcare Master Fund Ltd has made a total of 0 transactions in Avadel Pharmaceuticals PLC (AVDL) over the past 5 years. The most-recent trade in Avadel Pharmaceuticals PLC is the sale of 261,000 shares on June 23, 2017, which brought Broadfin Healthcare Master Fund Ltd around $3 Million.
According to the SEC Form 4 filings, Broadfin Healthcare Master Fund Ltd has made a total of 0 transactions in Corium International Inc (CORI) over the past 5 years. The most-recent trade in Corium International Inc is the sale of 500,000 shares on November 17, 2017, which brought Broadfin Healthcare Master Fund Ltd around $5 Million.
More details on Broadfin Healthcare Master Fund Ltd's insider transactions can be found in the Insider Trading History of Broadfin Healthcare Master Fund Ltd table.Insider Trading History of Broadfin Healthcare Master Fund Ltd
- 1
Broadfin Healthcare Master Fund Ltd Trading Performance
GuruFocus tracks the stock performance after each of Broadfin Healthcare Master Fund Ltd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Broadfin Healthcare Master Fund Ltd is 7.07%. GuruFocus also compares Broadfin Healthcare Master Fund Ltd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Broadfin Healthcare Master Fund Ltd within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Broadfin Healthcare Master Fund Ltd's insider trading performs compared to the benchmark.
Performance of Broadfin Healthcare Master Fund Ltd
Broadfin Healthcare Master Fund Ltd Ownership Network
Ownership Network List of Broadfin Healthcare Master Fund Ltd
Ownership Network Relation of Broadfin Healthcare Master Fund Ltd
Broadfin Healthcare Master Fund Ltd Owned Company Details
What does BioDelivery Sciences International Inc do?
Who are the key executives at BioDelivery Sciences International Inc?
Broadfin Healthcare Master Fund Ltd is the director of BioDelivery Sciences International Inc. Other key executives at BioDelivery Sciences International Inc include See Remarks James Vollins , See Remarks Mary Theresa Coelho , and director & Chief Executive Officer Jeffrey Allen Bailey .
BioDelivery Sciences International Inc (BDSI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of BioDelivery Sciences International Inc (BDSI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioDelivery Sciences International Inc (BDSI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
BioDelivery Sciences International Inc (BDSI)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioDelivery Sciences International Inc Insider Transactions
Broadfin Healthcare Master Fund Ltd Mailing Address
Above is the net worth, insider trading, and ownership report for Broadfin Healthcare Master Fund Ltd. You might contact Broadfin Healthcare Master Fund Ltd via mailing address: C/o 20 Genesis Close, Ansbacher House, 2nd Floor, Po Box 1344, Grand Cayman E9 Ky1-1108.